6 hours Compugen Gears Up to Report Q3 Earnings: Here’s What to ExpectZacks
On CGEN’s third-quarter 2024 earnings call, investors’ focus is likely to be on updates on its pipeline candidates being studied for cancer immunotherapies.
XOn CGEN’s third-quarter 2024 earnings call, investors’ focus is likely to be on updates on its pipeline candidates being studied for cancer immunotherapies.
X